Table 2.

Tendency of the anti-HCV-antibody-positive patients.

Complication of hepatitis 11

AST/ALT

Grade I/II 9

above Grade III 2

T-Bil

Grade I/II 1

above Grade III 1

HCV RNA elevation during chemotherapy 10

HCV RNA elevation with hepatitis 9

Reduction of transient HCV RNA after hepatic toxicity 5

Recurrence or refractory

Last time/first time HCV RNA below 1.0 0/5

Last time/first time HCV RNA above 1.0 8/8

Abberiviatins: HCV as hepatitis C virus; T-Bil as total bilirubin; AST as aspartate aminotransferase; ALT as alanine transaminase.